Trial
NCT00908856
Autologous Cell Therapy After Stroke
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of California, Irvine
Collaborators
University of California, San Diego
Condition
Stroke
Intervention
autologous bone marrow mononuclear cell transfusion
Why stopped
Not funded
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-02-04